The Federal Motor Carrier Safety Administration (FMCSA) is seeking public comment on applications from 11 individuals requesting exemptions from federal rules that generally prohibit people with epilepsy or other seizure-related conditions from operating commercial motor vehicles in interstate commerce. The applicants are seeking exemptions from FMCSA regulations that require commercial drivers to have no established medical history or clinical diagnosis of epilepsy or any condition likely to cause a loss of consciousness or loss of vehicle control.
If approved, the exemptions would allow the individuals to operate commercial vehicles across state lines despite having a history of seizures and, in most cases, continuing to take anti-seizure medications. This would enable them to pursue commercial driving opportunities that were previously unavailable due to their condition.
The 11 applicants come from various states across the US, including Alabama, Connecticut, Florida, Georgia, Missouri, Oklahoma, South Carolina, Vermont, and Wisconsin. Several already hold commercial driver's licenses, while others currently possess standard driver's licenses and are seeking the ability to pursue commercial driving opportunities.
FMCSA has operated an epilepsy exemption program since 2013, evaluating applicants based on medical records, driving histories, expert medical guidance, and public comments. The agency considers recommendations from a medical expert panel, along with each driver's individual circumstances, when determining whether an exemption should be granted.
The agency routinely grants exemptions, as seen in the recent approval of epilepsy waivers for 14 drivers in 2024. These drivers had remained seizure-free for extended periods while maintaining stable treatment regimens, and the FMCSA concluded that they were unlikely to experience seizures that would pose a risk to public safety.
Public comments on the latest applications will be accepted through June 29, allowing stakeholders to weigh in on the potential exemptions. The FMCSA will review the submissions, medical information, and safety analyses before determining whether the exemptions should be approved.
The epilepsy exemption program is an important consideration for commercial drivers who have been diagnosed with epilepsy or other seizure-related conditions. It highlights the need for a nuanced approach to regulating drivers with medical conditions that may impact their ability to operate a vehicle safely.
As the FMCSA reviews these applications, it must balance the need to ensure public safety with the need to accommodate drivers who can maintain a level of safety equivalent to or greater than that achieved under existing regulations.
The outcome of this review will have significant implications for commercial drivers and the industry as a whole, particularly in terms of access to employment opportunities and the development of more inclusive transportation policies.
The FMCSA's epilepsy exemption program has a track record of approving exemptions, but the process can be complex and requires careful consideration of individual circumstances.
